Цена акции Vir Biotechnology (VIR) сегодня, премаркет и постмаркет

Данные

Суперграфики

Legend

Ещё

Поиск

Vir Biotechnology, Inc.

VIR

Nasdaq

Health Technology

Biotechnology

8.80

USD

+0.11

+1.27%

Закрыт: 07-27 20:00 (UTC+0)

8.80

USD

+0.00%

После закрытия: 07-28 00:00 (UTC+0)

VIR Ключевая статистика

Максимум

9.09

Открыть

8.82

Объем

1.68M

Минимум

8.77

Предыдущее закрытие

8.69

Объем торгов

14.99M

Макс. 52 нед.

11.66

Отн. объем

1.022

Амплитуда (%)

3.62%

Мин. 52 нед.

4.16

Коэф. оборота

1.00%

Рыночная капитализация

1.46B

P/E (TTM)

P/E (год.)

2.234

P/B

1.8

P/S

22.38

Прибыль на акцию (EPS)

-3.137

Дивиденд (TTM)

Дивидендная доходность

0.00%

Акции в обращении

168.65M

Валюта

USD

VIR Доходность цены

7 день

30 день

90 день

180 день

С начала года

1 Год

VIR Распределение денежных потоков

VIR Дневной объем коротких продаж

VIR История short interest

Обзор акции VIR

As of 2026-07-28, the Vir Biotechnology, Inc. (VIR) stock price today is 8.8. Based on this price, the company has a market capitalization of $1.46B, with a P/E ratio of --. On 2026-07-28, VIR traded between 8.77 and 9.09. Today’s stock price is 0.34% above the daily low and 3.19% below the daily high, placing VIR ближе к нижней границе its most recent trading range. Trading volume currently stands at 1.68M, compared with an average daily volume of 1.65M. This suggests that trading activity is примерно соответствует обычному уровню than usual. Over the past year, Vir Biotechnology, Inc. shares have traded between 4.16 and 11.66. At today’s price, VIR is 111.54% above its 52-week low and 24.53% below its 52-week high.

VIR Связанные новости

О нас VIR

Название компании

Vir Biotechnology, Inc.

Сектор

Health Technology

Отрасль

Biotechnology

Биржи

Nasdaq

Количество сотрудников

367

Размер лота

100

Официальный сайт

www.vir.bio

Валюта

USD

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Related Stocks

VIR FAQ

1.What is the live stock price of Vir Biotechnology, Inc. (VIR) today?

3. What is the latest pre-market price of VIR?

5.How has VIR’s stock price performed recently?

7. What is the current capital flow for VIR?

9. What is the current price of NVDA stock perps?

11. What is the market capitalization of Vir Biotechnology, Inc.?

13. What is Vir Biotechnology, Inc.’s earnings per share (EPS)?

15. Does Vir Biotechnology, Inc. pay dividends?

17. How many employees does Vir Biotechnology, Inc. have?

2. What were VIR’s trading range and trading volume on the most recent trading day?

4.What is VIR’s after-hours price?

6. What are VIR’s 52-week high and 52-week low?

8. What are VIR’s short sale volume and short interest?

10. What are Vir Biotechnology, Inc.’s P/E ratio and valuation metrics?

12. What were Vir Biotechnology, Inc.’s revenue and net income in the most recent quarter?

14.What is Vir Biotechnology, Inc.’s total number of shares outstanding?

16. Which exchange is Vir Biotechnology, Inc. listed on, and what sector and industry does it belong to?

18. What risks should investors consider before investing in VIR?